<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Symptomatic intracranial stenoses are an important cause of <z:hpo ids='HP_0001297'>stroke</z:hpo> and have a high risk of recurrent <z:hpo ids='HP_0001297'>stroke</z:hpo> with medical therapy </plain></SENT>
<SENT sid="1" pm="."><plain>The Stenting and Aggressive Medical Management for Preventing Recurrent <z:hpo ids='HP_0001297'>Stroke</z:hpo> in Intracranial <z:hpo ids='HP_0100545'>Arterial Stenosis</z:hpo> (SAMMPRIS) trial unexpectedly showed a higher-than-expected rate of complications with intracranial stenting and a lower-than-expected recurrence rate with medical therapy </plain></SENT>
<SENT sid="2" pm="."><plain>In this commentary, the authors review possible explanations for these findings and suggest future strategies for study </plain></SENT>
</text></document>